Paratek Pharmaceuticals
formerly Paratek (formerly Transcept Pharmaceuticals)AcquiredParatek Pharmaceuticals is a biotech company in Boston, United States, founded in 1996. It has raised $1.8B across 3 rounds, most recently a $140.0M Convertible Note in April 2018.
Positive outcomes. Positive Patient Stories
- Headquarters
- Boston, Massachusetts
- Employees
- 201–500
- Founded
- 1996
- Business Model
- B2B
- Website
- paratekpharma.com
- Total Funding
- $1.8B
- Last Round
- $140.0M Convertible NoteApr 2018
- Rounds
- 3
- Acquisition Date
- Jun 2023
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 3 funding rounds and 9 investors for this company. The full record is or through the API.
About
Paratek Pharmaceuticals develops and commercializes specialty therapies for patients with infectious diseases and other difficult-to-treat conditions. Its FDA-approved portfolio includes NUZYRA (omadacycline), a tetracycline-class antibiotic for adult community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections, and XHANCE, a prescription nasal spray for chronic rhinosinusitis with or without nasal polyps. The company aims to be a leading independent pharmaceutical firm providing innovative specialty therapies that address life-threatening infections and complex medical needs.
Summary
It lists 201–500 employees. It has raised $1.8B in total across 3 rounds, most recently a $140.0M Convertible Note round in Apr 2018. Investors include Novo Holdings A/S, Gurnet Point Capital and Aisling Capital.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Jun 2023
Sign up to see all 7 events
Funding: Series C through Convertible Note. Amounts, valuations, and investors where available.
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
China's leading blood products manufacturer
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/paratek-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/paratek-pharmaceuticals" alt="Paratek Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>